Analyst Report: LITE

1. EXECUTIVE SUMMARY

Lumentum fell 18.68% to $509.70 on Thursday 5 November, the second 18% daily drop in four sessions. Under the all-stock deal announced on 2 November, each Lumentum share converts into 4.5 Marvell shares with no collar, so Lumentum's price follows Marvell's. TIKR reports Marvell fell another 15% on 5 November amid a broad selloff in AI optics and chip stocks. The brief names no Lumentum-specific news for that session. The stock has lost 44.57% in five sessions and sits well below the value of the offer. The fundamentals in the quarterly report are strong. The share price now depends mainly on Marvell's shares, on whether the merger closes, and on the AI trade.

2. THE CATALYST

Marvell announced a definitive all-stock agreement to acquire Lumentum on 2 November, alongside Lumentum's fiscal first-quarter results (Marvell press release, 2 November). Lumentum holders receive a fixed 4.500 Marvell shares per share. Marvell put the implied value at $1,132 per share, a premium of about 23.9% to the unaffected close of 28 October. The facts show that close as $913.95.

The 2 November session was the first reaction. Lumentum closed at $684.40, down 18.59% on 15,343,000 shares, the heaviest volume in the table. The brief does not give Marvell's move that day. TIKR (5 November) notes there is no collar, so Marvell's losses come straight out of the offer value. TIKR calculated that by the 4 November close the offer had fallen to about $719 per Lumentum share, with Marvell down roughly 37% from its pre-talks price.

The 5 November session was a second leg. TIKR says Marvell fell another 15% and that Lumentum "trades on Marvell's shares". Other optical names fell without a deal of their own: Coherent and Applied Optoelectronics dropped by double digits despite strong outlooks (TIKR and 24/7 Wall St., 5 November, the latter headline only). Yahoo Finance (5 November, headline only) reported a broad big-tech selloff with Nvidia in bear territory. Some headlines tie the AI chip decline to the midterm election result, but the brief could verify this only from a headline, so it remains a hypothesis.

The brief offers no explanation for the 8.57% fall on 30 October, the session before the announcement.

3. COMPANY PROFILE

Lumentum makes optical and photonic products. Components include semiconductor laser chips, laser sub-assemblies, line subsystems and wavelength management systems. Systems include optical modules, optical circuit switches and industrial lasers. Customers span cloud, AI and machine learning, and telecommunications. It sits in the Communication Equipment industry, and the peer set the site tracks includes Cisco, Arista, Ciena, Motorola Solutions and F5.

Fiscal first-quarter 2027 results (quarter ended 26 September, reported 2 November) were strong (Lumentum release; 24/7 Wall St.):

• Revenue was $1.26bn, up 136.5% year over year.
• Non-GAAP EPS was $4.57, against about $4.22 expected, and GAAP EPS was $3.54.
• Second-quarter guidance calls for revenue of $1.575bn to $1.625bn, non-GAAP EPS of $5.90 to $6.20 and a non-GAAP operating margin of 45% to 46% (Nasdaq press release).
• Management says optoelectronic capacity is effectively sold out and cites a second NPO/CPO design win with more than $5bn of purchase commitments (24/7 Wall St.).
• Cash fell $758.8m to $2.0bn during the quarter (Lumentum release).

On governance, CEO Michael Hurlston and two other Lumentum directors join Marvell's board, and Marvell's Matt Murphy stays chairman and CEO of the combined company. A Form 425 memo says the companies operate separately until closing, which is expected in the first half of 2028 pending shareholder and regulatory approvals.

4. DEEP DIVE ANALYSIS

Do the fundamentals justify the move? The quarter and guidance give no reason for a fall of this size. The decline is a mark-down of the Marvell shares Lumentum holders will receive. TIKR's $719 offer value at the 4 November close compares with Lumentum's $626.75 close that day, a gap of about $92. Applying Marvell's further 15% drop to $719 gives an offer value near $611 on 5 November, against a $509.70 close, a gap of roughly $100. That is the author's arithmetic from brief figures. The gap is consistent with the market pricing some chance the deal does not close or that Marvell falls further before the first-half 2028 closing date.

Valuation. At $509.70 the market cap is $46.22bn and the forward P/E is 13.1. Management guides to second-quarter non-GAAP EPS of $5.90 to $6.20, while the facts carry a consensus estimate of $4.22 for the 2 February report. That estimate matches the figure the quarter just beat, so it probably predates the guidance (inference).

Analyst reaction. Every target in the brief sits above the current price, but most were set before the 5 November leg. These come from Investing.com and Yahoo Finance summaries, not the primary notes.

One Investing.com piece has B. Riley moving LITE to Neutral, while another names it a top AI optics pick with a Buy. A Yahoo article supports the Neutral version. On the Marvell side, TD Cowen cut MRVL to Hold with a $175 target from $350, and Bank of America cut it to Neutral with a $225 target from $400. B. Riley cut its MRVL target to $275 and kept its Buy rating.

Peers and sector. Lumentum fell more than every peer in the set while the S&P 500 lost 4.36%.

TIKR attributes the declines at Ciena and Credo to investors cutting AI connectivity exposure broadly after strong quarters. Cisco fell after a Morgan Stanley downgrade (24/7 Wall St., headline only). Applied Materials dropped in sympathy, and Qualcomm's weak guidance and Arm's royalty miss hit chip stocks overnight (TIKR). Bank of America's note put the semiconductor index down about 19% over the prior month. No source explains why MSI rose.

Comparable episodes. The 2 November session is the closest precedent in the window: a deal-driven drop followed by further declines as Marvell fell. The brief sourced no earlier Lumentum selloff with a similar cause.

Bull case. The business is growing fast and capacity is sold out. A forward P/E of 13.1 is low for that growth. The fixed ratio gives holders 4.5 Marvell shares, so a Marvell recovery lifts Lumentum one-for-one. Several targets, including $1,328 and $1,132, sit far above the price. The Information (4 November, headline only) reported a higher chance of an alternate bid after the selloff, which the brief could not confirm.

Bear case. Lumentum holders bear all of Marvell's equity risk and none of the cash protection a collar would give. The close is 15 to 20 months away, with shareholder votes and regulatory approvals ahead. Two Marvell downgrades show analysts questioning the structure. Wedbush questions whether the deal completes (headline only). Lumentum's cash fell to $2.0bn in the quarter, and the AI connectivity trade has turned against the whole sector.

5. TECHNICAL SNAPSHOT

The $509.70 close is the lowest in the daily table, so no support level appears in the data. The nearest resistance is the 4 November close of $626.75. The price sits below the 50-day average of $902.49 and the 200-day average of $806.74, and 55.4% below the 52-week high of $1,143.00 set on 9 October. It remains well above the 52-week low of $213.00. The stock opened at $594.20, a gap below the prior close, and traded as low as $506.69 against a high of $596.82, closing near the low. Volume of 9,929,500 was 1.91x the 50-session average, below the 15,343,000 recorded on announcement day.

6. RISK FACTORS

• Marvell's share price: with no collar, each further decline in Marvell passes straight to Lumentum.
• Sector sentiment: the AI optics and chip selloff has hit companies with strong results and no deal, so earnings beats have not stopped the declines.
• Deal completion: shareholder votes, regulatory approvals and a first-half 2028 close leave a long period of exposure. No vote date has been set.
• Source quality: the election link, the Wedbush note and The Information's alternate-bid report are headline only. Analyst targets come from secondary summaries.

7. ACTIONABLE OUTLOOK

Short term (1-2 weeks): Marvell's share price and the AI chip tape set the direction. A stabilisation in Marvell would likely bring a rebound toward $626.75, the nearest resistance. Another leg down in AI names pushes Lumentum below the 5 November low of $506.69. Volume has stayed between 7.2 million and 15.3 million shares a session since the announcement, and the stock has fallen on each heavy day.

Medium term (1-3 months): Marvell's early December results are the main event, since they set the value of 4.5 shares. Lumentum's gap to the offer value narrows if Marvell steadies, and the S-4 filing adds detail on terms and timing. A competing bid, which one headline floats, would reprice the stock, but nothing confirms it.

Long-term thesis: The operating thesis of sold-out capacity, a 136.5% revenue increase and a second NPO/CPO design win has not changed. The investment case has changed in form, because holders now own an economic interest in the combined Marvell-Lumentum company, whose value depends on Marvell's shares and on the deal closing. This is analysis, not personal financial advice.